Both Semaglutide and copyright represent a group of drugs called Glucagon-like Peptide-1 receptor agonists . These important treatments operate by imitating the body's inherent substance, Glucagon-like Peptide-1, to assist lower glucose levels and promote weight loss . This similar mechanism of effect explains why such therapies are commonly evalua